These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2250958)

  • 1. [Statistical results of 700 electrophysiologic tests (ERG) in patients without ophthalmologic manifestations treated with synthetic antimalarials for rheumatologic or dermatologic disease].
    Rigaudière F; Pizzato M; Albuisson E; Le Gargasson JF; Grall Y
    Ophtalmologie; 1990; 4(3):254-9. PubMed ID: 2250958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The ERG contribution in early diagnosis of chloroquine and hydroxychloroquine maculopathy].
    Karkanová M; Matusková V; Vlková E; Dosková H; Uhmannová R
    Cesk Slov Oftalmol; 2010 Apr; 66(2):62-6. PubMed ID: 20925239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography.
    Lyons JS; Severns ML
    Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular damage in chloroquine therapy.
    Nylander U
    Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract]   [Full Text] [Related]  

  • 6. Keratopathy with low dose chloroquine therapy.
    Cullen AP; Chou BR
    J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
    Lai TY; Chan WM; Li H; Lai RY; Lam DS
    Am J Ophthalmol; 2005 Nov; 140(5):794-807. PubMed ID: 16310457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eye toxicity of antimalarial agents].
    Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
    An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transitory retinopathy caused by prolonged treatment with hydroxychloroquine sulfate].
    Chiari JJ; Freyberg RH
    Arch Med Panamenos; 1965 Apr; 14(1):23-32. PubMed ID: 5839434
    [No Abstract]   [Full Text] [Related]  

  • 10. Current practices for monitoring ocular toxicity related to hydroxychloroquine (Plaquenil) therapy.
    Mazzuca SA; Yung R; Brandt KD; Yee RD; Katz BP
    J Rheumatol; 1994 Jan; 21(1):59-63. PubMed ID: 8151589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electroretinography in 83 patients treated with synthetic antimalarials].
    Bertrand JJ
    Bull Soc Ophtalmol Fr; 1966 Oct; 66(10):885-907. PubMed ID: 5991635
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal pigment epithelial dysfunction in human immunodeficiency virus-infected patients with cytomegalovirus retinitis.
    Harrison JM; van Heuven WA
    Ophthalmology; 1999 Apr; 106(4):790-7. PubMed ID: 10201604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
    Leecharoen S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of red amsler grid screening in a rheumatology clinic.
    Pluenneke AC; Blomquist PH
    J Rheumatol; 2004 Sep; 31(9):1754-5. PubMed ID: 15338495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmologic monitoring for antimalarial toxicity.
    Sfikakis PP; Mavrikakis M
    J Rheumatol; 2004 May; 31(5):1011-2; author reply 1012. PubMed ID: 15124272
    [No Abstract]   [Full Text] [Related]  

  • 17. Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases.
    Costedoat-Chalumeau N; Hulot JS; Amoura Z; Leroux G; Lechat P; Funck-Brentano C; Piette JC
    Rheumatology (Oxford); 2007 May; 46(5):808-10. PubMed ID: 17202178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal antimalarial-induced cardiomyopathy: report of 2 cases.
    Azimian M; Gultekin SH; Hata JL; Atkinson JB; Ely KA; Fuchs HA; Mobley BC
    J Clin Rheumatol; 2012 Oct; 18(7):363-6. PubMed ID: 23047537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Routine monitoring of patients treated with synthetic antimalarials].
    Douche C; Bechetoille A; Ebran JM
    J Fr Ophtalmol; 1983; 6(8-9):689-95. PubMed ID: 6677659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis].
    Laaksonen AL; Koskiahde V; Juva K
    Duodecim; 1974; 90(2):125-31. PubMed ID: 4848261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.